Table II.
Antibiotic therapy regimens for hospital-acquired pneumonia.
| HAP | Drug | Dose | Route | Duration |
|---|---|---|---|---|
| First line | Cefepime OR piperacillin/tazobactam OR meropenem + macrolide |
2000 mg BID 4500 mg TID-QID 1000 mg TID |
Intravenous | 10-14 days |
| Methicillin-resistant Staphylococcus aureus (MRSA) | Vancomycin OR Linezolid + macrolide |
1000 mg BID 600 mg BID |
Intravenous | 10-14 days |
| Vancomycin-resistant Staphylococcus aureus (VRSA) | Ceftarolina OR ceftobiprolo + macrolide |
600 mg BID | Intravenous | 10-14 days |
| Pseudomonas A. | IV generation cefalosporin + ciprofloxacin OR amikacin |
400 mg BID 15 mg/kg DIE |
Intravenous | 10 days |